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To Thee It Shall Descend With Better Quiet
—From Act IV, Scene III, Henry IV, Part II,
by William Shakespeare
Coronary artery disease (CAD) is a devastating disease
precisely because an otherwise healthy person in the prime
of life may die or become disabled without warning. When
the afflicted individual is under the age of 40, the tragic
consequences for family, friends, and occupation are partic-
ularly catastrophic and unexpected. Fortunately, the inci-
dence of myocardial infarction (MI) and symptomatic CAD
in young adults is low; most studies show that only about
3% of all CAD cases occur in this age range (1).
The fact that clinically manifest CAD in the young adult
is relatively uncommon implies that these patients are
atypical of the general population. It must be noted,
however, that those patients who come to medical attention
owing to symptomatic disease may well represent the “tip of
the iceberg” when considering manifest and subclinical
disease together. Because young, asymptomatic patients
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typically do not undergo medical investigations leading to
the serendipitous discovery of CAD, the true prevalence of
the disease has been grossly underestimated. Indeed, when
a rigorous intravascular ultrasound-based investigation was
undertaken in a cohort of recently transplanted hearts (mean
donor age 33.4  13.2 years) by Tuzcu et al. (2), the
prevalence of disease was 50%, with one in six teenagers
manifesting coronary lesions.
Many early studies (3) evaluating these patients labeled
them as having “premature” CAD, but it is now better
understood as a rapidly progressive form of the disease
(4–6). Subsequently, this subgroup has been the subject of
numerous observational series seeking to identify what sets
them apart (7). It is well recognized that these patients are
mainly male and have several coronary risk factors, but this
is a statement easily made of many older CAD patients as
well (8,9).
RISK FACTORS
Cigarette smoking has been the single factor most strongly
associated with CAD in the young adult. Kannel et al. (10)
found in patients included in the Framingham Heart Study,
the relative risk for CAD was about three times higher in
smokers age 35 to 44, compared to nonsmokers. Repeated
exposure to cigarettes and the resulting frequent catechol-
amine surges damage endothelial cells, leading to dysfunc-
tion and injury of the vascular intima. Cocaine, especially
taken in combination with tobacco or as concentrated
cocaine hydrochloride base (“crack”), is especially likely to
produce spasm, plaque rupture, and thrombosis by a similar
mechanism but with greater intensity. Coronary vasospasm
may occur in angiographically normal coronary arteries even
in the absence of stimulants or sympathomimetic agents.
Several cases have been reported of acute MI in young
patients with acute ethanol intoxication and no evidence of
CAD by intravascular ultrasound. Although the precise
pathogenetic mechanism remains elusive in these cases,
disrupted coronary vasomotor tone with resultant vasospasm
is strongly suspected (11).
Diabetes and hyperlipidemia are also frequently present
in young CAD patients. Whereas the importance of these
factors in the pathogenesis of CAD and their powerful
relationship to rapid disease progression is well documented
(12,13), their importance in this population is not charac-
terized in detail. Although markedly elevated levels of total
cholesterol, low-density lipoproteins, and triglycerides are
found in some young CAD patients, few studies have
systematically analyzed the lipid panels of this population of
patients. Isser et al. (14) found significant elevation of
triglycerides and lipoprotein (a) (Lp[a]) levels and depres-
sion of high-density lipoprotein (HDL) cholesterol in
young patients presenting with their first MI, compared
with age- and gender-matched controls. Interestingly, there
was also noted to be strong familial clustering of Lp(a)
elevation in the asymptomatic first-degree relatives of these
patients. Similarly, although insulin-dependent diabetics are
at high risk for CAD, diabetes is found in only about 15%
to 20% of all young CAD patients. Even less well studied in
this regard is the relative risk posed by atherogenic subfrac-
tions of low- and high-density lipoproteins, hyperhomocys-
teinemia, elevated fibrinogen, and abnormal blood viscosity.
Recent data (15) suggest that elevated homocysteine and
elevated Lp(a) are independent risk factors for the develop-
ment of CAD in young men; however, these two factors
appear to interact in a synergistic fashion to confer risk in
young women.
Young women with CAD comprise an especially inter-
esting group given the protective effect of estrogen, but
which factors are predictive in this distinctly unusual cohort
is poorly understood (1). Anecdotal cases suggest that
diabetes in women may have a more powerful role than in
men. Women who smoke have a quantitatively similar risk
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as men (16), but more than five times the risk of nonsmok-
ing women (17). Smoking in combination with oral con-
traceptives poses a 13-fold increase in CAD mortality (18).
Truncal obesity and increased body mass index (BMI) have
recently been proposed as potential independent risk factors,
particularly in young women with CAD. In one cohort of
young CAD patients (19), the addition of the logarithmi-
cally transformed BMI to the Framingham risk score
yielded a substantial increase in predictive power for CAD
as assessed by the detection of coronary artery calcification.
Augmentation in the area under the receiver-operating
characteristic curve was more pronounced in women, but
incorporation of BMI data was found useful across the
entire study population as well. Other cases of plaque
rupture are typically ascribed to spasm, spontaneous coro-
nary dissection, or trauma without overt recognition of
subclinical CAD. Patients with hypercoagulable states and
certain connective tissue or collagen vascular disorders
comprise a population also at high risk for early ischemic
events.
Family history is a factor known to be present in many of
these patients and probably represents a combination of risk
factors that are genetically determined. These include dia-
betes, lipid and thrombotic disorders, as well as a behavioral
predisposition to smoking. A growing body of evidence, for
example, shows that specific lipid abnormalities may be
genetically transmitted to the offspring of patients with
severe CAD. Uiterwaal et al. (20) found lower levels of
HDL3 cholesterol and apolipoprotein A2 in male children
of CAD patients. Similar but more modest trends were also
identified in the female children of these patients.
Perhaps of equal interest is the lack of a strong association
of other traditional risk factors to CAD in the young.
Hypertension and lack of exercise are both firmly estab-
lished risk factors for CAD in general, but they appear to
contribute only marginally in this population. Undoubtedly,
accounting for the surprising absence of a powerful influ-
ence of these factors in this population is important in fully
comprehending the pathogenesis of CAD in young adults.
Almost entirely unexplored are the roles of emotional
distress, anger, and sudden or extreme physical exertion. In
a subgroup analysis of the Coronary Artery Risk Develop-
ment in Young Adults (CARDIA) study (21), high objec-
tive hostility scores were associated with the presence of
coronary artery calcification. This intriguing data suggests
the possible involvement of risk factors that are often not
considered in typical risk-stratification schemes. Consider-
ing the occasional involvement of these factors in older
CAD patients, their involvement in this group should be
further elucidated. Similarly understudied is the role of
inflammation, either measured by systemic inflammatory
markers such as high sensitivity C-reactive protein, or
manifest as frank vasculitis. Because chlamydia, myco-
plasma, and H. pylori are often thought of as having a
pathogenetic role in CAD, this population would seem to
be an ideal group to study for the presence of recent
infections. We recently observed a young man with an acute
MI who exhibited acute and six-month titers strongly
suggesting a mycoplasma infection at the time of his acute
infarct. Emotional stress and smoking were also present. He
has had no recurrent CAD events after three years of
follow-up.
EXTENT OF ATHEROSCLEROSIS AND PROGNOSIS
Numerous studies (4–7) have demonstrated the surprisingly
good prognosis up to three years after diagnosis of CAD in
the young adult. Patients who undergo coronary angiogra-
phy soon after acute MI typically have less extensive CAD
and higher ejection fractions than older MI patients (7).
They have fewer comorbidities, are less disabled by recur-
rent angina and heart failure, and are more likely to return
to work. Presentation with symptomatic CAD but without
an acute infarction is uncommon, perhaps not surprisingly
given the likelihood of overlooking the diagnosis in young
patients with chest pain (7).
Klein et al. (7) theorized that two distinct populations
exist. The more common subgroup is characterized by
single-vessel, and often single-stenosis, disease, presumably
related to acute plaque rupture, with an excellent three-year
outcome. The favorable prognosis was believed to be related
to preserved left ventricular function without multivessel
involvement. The less common group has extensive three-
vessel CAD with “galloping” progression unrestrained by
coronary artery bypass graft surgery (CABG) and preventive
measures. However, an attractive explanation for this di-
chotomy was unclear at the time this hypothesis was
proposed, because once plaque rupture occurs, that individ-
ual’s propensity to form vulnerable plaque is unquestionable.
CURRENT STUDY
In this issue of the Journal, Cole et al. (22) from Emory
University in Atlanta, Georgia, report on the 15-year
follow-up of 843 patients who had angiographically docu-
mented CAD under age 40. Both in terms of length of
follow-up and sample size, this is by far the largest obser-
vational series ever published. The investigators found
diabetes and smoking to be predictive of mortality, along
with prior MI and heart failure. The latter two variables are
not surprising, but the independent impact on outcome of
these two risk factors surely has a deeper pathogenetic
meaning. Furthermore, the investigators show that, contrary
to previous studies, the 15-year outcome is not favorable—a
30% mortality overall is found. Interestingly, those treated
medically, in contradistinction to those receiving early
revascularization with percutaneous coronary intervention
or CABG, had a worse outcome. It remains unclear,
however, to what extent this finding is reflective of selection
bias related to extent and severity of disease. The fact that
angina class (at time of presentation) and number of vessels
diseased at index catheterization were not predictive of
long-term outcome is inconclusive, for it is the speed of
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disease progression over this long time frame, rather than
initial findings, which would be the most crucial variable.
The revascularization strategy analysis is important and
unique, and it adds a great deal to our understanding.
However, this analysis only evaluated mortality as an end
point. Further studies should consider repeat MI, heart
failure, repeat revascularization, and recurrent chest pain/
hospital admission. Further, an assessment of disease pro-
gression is key.
PATHOGENETIC MECHANISMS
Clearly, this is a fascinating patient group with an important
story to tell, but we are just beginning to listen carefully
enough to hear. The existing observational data allow a
modification of the earlier hypothesis. The two subgroup
categorizations remain valid, but the interplay with risk
factors can now be better sketched into the picture.
In young patients with a single culprit lesion, and among
most women (especially those with dissection or coronary
spasm), a plaque rupture on a previously nonsignificant
vulnerable plaque is usually the mechanism of acute presen-
tation. Such cases are likely related to acute physical and/or
emotional stress, resulting in enhanced coronary shear
forces. If these patients do not alter their lifestyles, CAD
progression at an earlier age than usual will result, but it may
be avoided by following established preventive measures.
This group has a substantial vasospastic component super-
imposed on a genetic predisposition to vulnerable plaque
production.
Conversely, a second group is comprised of those with
diabetes and others who present with established multivessel
disease (including those related to lipid abnormalities).
These patients are most likely to have rapid progression of
a more typical form of CAD. They will experience only
short-term benefit from revascularization, unless very ag-
gressive control over risk factors is strictly adhered to.
The interaction between a genetic propensity to form
vulnerable plaque combined with acute stress and/or an
active infectious/inflammatory process needs further study.
If we can better identify and characterize the mechanism of
disease in this population, our understanding of CAD in
more typical cases will be vastly improved.
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